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Background: Plasmodium falciparum exports proteins that remodel the erythrocyte membrane. One such protein,
called Pf155/RESA (RESA1) contributes to parasite fitness, optimizing parasite survival during febrile episodes. Resa1
gene is a member of a small family comprising three highly related genes. Preliminary evidence led to a search for
clues indicating the involvement of RESA2 protein in the pathophysiology of malaria. In the present study, cDNA
sequence of resa2 gene was obtained from two different strains. The proportion of P. falciparum isolates having a
non-stop T1526C mutation in resa2 gene was evaluated and the association of this genotype with severity of
malaria was investigated.
Methods: Resa2 cDNAs of two different strains (a patient isolate and K1 culture adapted strain) was obtained by
RT-PCR and DNA sequencing was performed to confirm its gene structure. The proportion of isolates having a
T1526C mutation was evaluated using a PCR-RFLP methodology on groups of severe malaria and uncomplicated
patients recruited in 1991–1994 in Senegal and in 2009 in Benin.
Results: A unique ORF with an internal translation stop was found in the patient isolate (Genbank access number :
JN183870), while the K1 strain harboured the T1526C mutation (Genbank access number : JN183869) which affects
the internal stop codon and restores a full length coding sequence. About 14% of isolates obtained from Senegal
and Benin harboured mutant T1526C parasites. Some isolates had both wild and mutant resa alleles. The analysis
excluding those mixed isolates showed that the resa2 T1526C mutation was found more frequently in severe
malaria cases than in uncomplicated cases (p = 0.008). The association of the presence of the mutant allele and
parasitaemia >4% was shown in multivariate analysis (p = 0.03) in the group of Beninese children.
Conclusions: All T1526C mutant parasites theoretically have the ability to give rise to a full-length RESA2 protein.
This study raises the hypothesis that the RESA2 protein could favour high-density infections. Other studies in
various geographic settings and probably including more patients are now required to replicate these results and
to answer the questions raised by these results.
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The reasons why certain Plasmodium falciparum-
infected patients develop severe malaria (SM) complica-
tions are unclear. Most studies on SM have focussed on
cyto-adhesion of erythrocytes infected with late stage
parasites, immunological disorders or host genetic sus-
ceptibility [1]. However, SM is usually associated with a* Correspondence: remy.durand@avc.aphp.fr
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burden. The parasite, which reproduces by a 1012 factor
in a few weeks, has evolved pathogenicity and virulence
factors that determine the infection outcome. Variations
in virulence may result from an increased parasite cap-
acity to uptake nutriments and/or a more efficient efflux
of waste material, high multiplication rate, optimal re-
modelling of the host infected erythrocytes and resist-
ance to host defenses such as fever and adaptive immune
response. In this regard, ring stages have received little
attention, despite their critical role in parasite installationLtd. This is an Open Access article distributed under the terms of the Creative
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Ring stages are exposed to fever, a hallmark of malaria
disease, which is triggered by toxic materials released
upon rupture of the infected erythrocyte. Febrile tem-
peratures are detrimental to parasite development of late
[2] but also of young stages [3,4].
As P. falciparum enters the erythrocyte, it progressively
modifies the structural components and the machinery of
its host cell in order to create an adequate environment
and to overcome host responses. Thus, immediately after
invasion, P. falciparum exports proteins that remodel the
erythrocyte membrane, modifying its mechanical, func-
tional and antigenic properties. One such protein, called
Pf155/RESA (RESA1), localized in the erythrocyte mem-
brane upon invasion and interacting with the erythrocyte
cytoskeleton protein spectrin, stabilizes the infected red
blood cell cytoskeleton, thereby allowing it to overcome
membrane weakening upon exposure at febrile tempera-
tures [4-6]. Thus, ring stage expression of RESA1 contri-
butes to parasite fitness, optimizing parasite survival during
febrile episodes. RESA1 has also been shown to be targeted
by the adaptive immune response in populations living in
endemic areas. Antibodies reacting with RESA1 inhibited
erythrocyte invasion [7-10] moreover were associated with
protection against clinical malaria [11-15]. Completion of
the P. falciparum genome sequence showed that resa1
gene is a member of a small family comprising three highly
related genes (PFA0110W resa1, PF11_0512 resa2 and
PF11_0509 resa3) that share similar erythrocytic stage tran-
scription profile. The role of RESA3 is still unknown.
The resa2 gene (accession number M91672) was first
reported as a pseudogene based on the presence of an
internal stop codon [16]. Interestingly, SNP affecting the
third base of this internal stop codon is described in
PlasmodB with the replacement of the internal stop
codon by a Glutamine codon in some laboratory parasite
strains (e.g. K1). This T1526C mutation may restore a
unique open reading frame and thus the ability to give
rise to a full-length protein. Large differences in resa2
gene transcription in vitro have been reported [16,17]
and increased transcription of this gene was observed
after parasite exposure at 41°C [3]. In vivo, resa2 behave
as a transcribed pseudogene [18] and analysis of gene ex-
pression profiles in malaria patients has consistently out-
lined resa2 expression and up-regulation in vivo [18-20].
In addition, a preliminary study indicated that isolates
with high parasitaemia harboured frequently mutated
T1526C resa2 gene (data not shown). Thus, preliminary
evidence led to a search for clues indicating the involve-
ment of RESA2 in the pathophysiology of malaria. In the
first part of the present study, the resa2 cDNA gene
structure from two different strains with or without the
T1526C mutation was determined. RFLP study was per-
formed to investigate the presence of the T1526Cmutation in P. falciparum isolates obtained in two geo-
graphical settings in Benin and Senegal and the associ-
ation of this genotype with the severity of malaria attack
was investigated.
Methods
Study areas and sample collection
Senegalese patients and samples have been described in
Robert et al [21]. Briefly, two groups of patients were
recruited at the Hôpital Principal de Dakar. The first group
corresponded to SM patients (aged <1 to 63 years) admit-
ted to the Intensive Care Unit (27 children and 29 adults).
All presented at least one of the symptoms defined by the
World Health Organization [22] as criteria for severe mal-
aria (severe anaemia, altered conciousness (Glascow Coma
Scale score of≤ 9), convulsions, hypoglycaemia, acidosis,
respiratory distress and impaired visceral functions). The
second group consisted of 30 outpatients with an uncom-
plicated malaria attack (UM) (see Additional file 1 and
Additional file 2). From April to August 2009, 101 children
with symptomatic P. falciparum malaria were recruited in
the CNHU of Cotonou, Benin. These children lived in the
urban area of Cotonou where malaria transmission is per-
ennial, with two seasonal peaks corresponding to rainy
seasons, from April to July and September to November.
A survey conducted in 2000 showed heterogeneous mal-
aria transmission in the city of Cotonou, with transmission
varying from five, 29 and 47 infective bites per person per
year near the beach, in the centre of the city and in the
outer-urban lagoon areas, respectively [23].
The inoculation rates were undoubtedly lower during
the study period, due to the introduction of effective pre-
vention and therapy. At admission, children were
assigned to the SM or the UM group as described else-
where [24]. Children age, gender, place of residence,
anti-malarial drug intake by the patient, and duration of
symptoms prior to enrolment were documented by ques-
tionnaire. For each individual a 5 mL venous blood was
collected in EDTA VacutainerW tubes before drug treat-
ment administration. Peripheral parasitaemia at admis-
sion was assessed by microscopy on Giemsa-stained
blood films and blood smears. In addition, for each indi-
vidual, two drops of fresh blood were collected onto fil-
ter paper for molecular study.
Characteristics of the recruited Beninese subjects are
presented in Additional file 3 and Additional file 4. Forty-
seven subjects and 54 subjects were included in the UM
group and in the SM group, respectively. The sex ratio
(M/F) of the SM group [1.7 (34/20)] did not differ signifi-
cantly from that of the UM group [1.35 (27/20)]. Subjects
with UM were older than children with SM (mean; SD
107.2 months; 156.6 vs 34.8 months; 21) (Mann Withney
test, p< 0.001, for comparison between the groups).
Patients of the SM group had higher parasite density than
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Forty-seven children had severe malarial anaemia only,
one child had cerebral malaria only, and six children had
both severe anaemia and cerebral malaria.
This Beninese study was approved by the ethics com-
mittee of the “Faculté des Sciences de la Santé” of the
University of Abomey-Calavi in Benin. For each child, a
written informed consent from parents or legal guar-
dians was obtained. The study was conducted in accord-
ance with the Declaration of Helsinki.In vitro culture growth assay
Leukocytes were removed from infected blood following
dilution with equal volume of phosphate-buffered saline
(PBS) and separation on Ficoll-Paque density gradient.
Depleted blood was washed three times in PBS. Infected
erythrocytes were suspended in complete RPMI culture
media supplemented with 10% human AB-positive
serum at a haematocrit of 5%. For isolates with parasit-
emia >5%, dilution with washed non-infected 0+ RBC
obtained from a unique non-P. falciparum infected
donor was performed. Parasites were cultured for 72
hours at 37°C using the candle jar method [25] and cul-
ture medium was changed daily.
DNA extraction
Parasite DNA was extracted from blood spots with
InstageneW Matrix resin (BioRad©, Marnes la Coquette,
France), according to the manufacturer’s instructions.
DNA genotyping
Oligonucleotides used for the polymerase chain reac-
tion (PCR) were selected in order to specifically amplify
the RESA2 sequence and to not cross-hybridize with
RESA1 or RESA3. PCR amplifications were performed
in 50μL reaction buffer (50 mM KCl, 10 mM Tris–HCl,
pH8.3) containing 3 μL of DNA solution, 0.4 μM each
primer 5′TGATGCCGTAAAAGATGGTG3′ (sense)
and 5′TCATATCTGCATTTATATCGACACCT′ (anti-
sense), 250 μM each dNTP, 3 mM MgCl2, and 1.25 U of
Thermus aquaticus DNA polymerase (AmpliTaq Gold;
PerkinElmer Life and Analytical Sciences, Boston, MA,
USA). The samples were incubated for 7 min at 95°C
for denaturation before cycles (95°C for 40 sec, 55°C for
40 sec, and 72°C for 40 sec). After 40 cycles, primer ex-
tension was continued for 7 min at 72°C. PCR products
were then submitted to the restriction enzyme MseI
(New England BioLabs, Beverly, MA, USA), analysed
by 1% agarose gel electrophoresis, and visualized by
ethidium bromide staining under UV light. The pres-
ence of the T1526C SNP that codes for the substitution
of the stop codon by a Glutamine codon leaves the PCR
fragment uncut by the restriction endonuclease MseI.RT-PCR
Saponin-treated, ring-stage parasites were harvested by
centrifugation, and lysed in 10 pellet volumes of Trizol
(Gibco) before freezing at −80°C. Total RNA was pre-
pared from thawed samples following the manufac-
turer’s instructions. RNA was treated with DNAse I
(Invitrogen) for 15 min at 37°C in presence of RNAse-
OUT™ inhibitor (Invitrogen). PF11_0512 mRNA was
transcribed from 1 μg RNA into cDNA using Titan One
tube RT-PCR kit (Roche) in a final volume of 50 μl of re-
action buffer containing 0.2 mM dNTP each, 5 mM
dithiothreitol, 5 unit RNAse inhibitor, 0,4 μM primer 5′
CGCTCGAGATGAAACAACATAGTTC and primer 3′
GGCAGATCTTTTTAATAGTTCATTTATTGTG, and
1 μl of enzyme mix (AMV reverse transcriptase, Taq DNA
polymerase and Tgo DNA polymerase). After 30 min incu-
bation at 48°C, the reaction was terminated at 94°C for 2
min and immediately processed for PCR amplification.
Thirty-five temperature cycles were conducted as follows:
denaturation at 94°C for 30 sec, annealing at 52°C for 30
sec, and extension at 68°C for 2 min 50 sec with a 3-min
final time increment.Cloning and sequencing of resa2 cDNA
Resa2 cDNA product was purified and cloned into ZERO
Blunt TOPO vector (InvitrogenW) following the manu-
facturer’s recommendations and sequenced using MWG
Eurofins company services with Sp6 and T7 primers or
resa2 specific primers.Data analysis
Data from the two patients groups of Benin and Senegal
were combined to assess the association between mu-
tant allele and severity of malaria. As some isolates har-
boured both wild and mutated parasites and because the
proportion of each genotype was unknown, two differ-
ent analyses were performed: in the first one, mixed iso-
lates were merged with mutant isolates and compared
with wild isolates; in the second analysis, mixed isolates
were excluded from the analysis and mutant isolates
were compared with wild isolates. Because the two
groups differed in terms of seasonality of malaria trans-
mission and in terms of age, the odds ratio of mutant al-
lele were adjusted for age and country. Groups were
compared using the Wilcoxon ranksum test for continu-
ous variables and the Fisher’s exact test for categorical
variables. Then a logistic regression was conducted to
identify factors associated with mutant alleles, and to es-
timate odds ratios and 95% confidence intervals (CI) for
the association between exposure variables and mutant
alleles. Statistical analysis was performed using Stata 10
(Stata Corporation, College Station, TX, USA).
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Gene structure
Previous predictions based on alignment with resa1
gene generated a gene model with a single intron and an
internal TAA stop codon in resa2 exon 2 [16]. Partial se-
quencing of the resa2 mRNA expressed in vivo by para-
sites collected from an infected Saimiri monkey was
consistent with this model [19]. However, the actual
bio-informatic prediction in PlasmodB (PlasmodB 8.1)
indicates the presence of two additional introns, which
once spliced out, remove the stop codon in the resa2
mRNA.
To clarify the gene structure, amplification of resa2
cDNA by RT-PCR was performed using P. falciparum
RNA purified from a patient isolate and the K1 culture
adapted strain. Sequencing analysis of cloned RT-PCR
fragment product showed that a single intervening se-
quence is spliced out in the final mRNA. A very minor
band, about 100 bp smaller, was also visible following
RT-PCR, and may correspond to the PlasmodB predicted
cDNA. However cloning failure of this minor product
excluded assessment of this prediction. A unique ORF
with the described premature translation stop was found
in the patient isolate [Genbank access number:
JN183870], while the K1 strain harboured the T1526C
mutation [Genbank access number: JN183869]. Thus,
resa2 behaved as a transcribed pseudogene in some
strains harbouring the T1526 allele, and as a normal
gene in those possessing a 1526C allele, which codes for
a full length coding sequence.
PF11_0512 sequence available in both PlasmodB and
GenedB database also differs from the original se-
quence by a frameshift in the coding sequence, an
event not detected in both K1 and SAMA cloned cDNA
sequence reported here. This frameshift results from
different A residues in a polyA stretch, which was
found to be associated to frequent polymerase slippage
as evidenced by sequencing of many uncloned or
cloned PCR products encompassing this region. Inter-
estingly, Blast analysis against P. falciparum sequences
available at Broad Institute or Sanger Institute indi-
cated that number of A residues in this genomic region
may differ; some strains, such as Santa Lucia strain or
Ghanaian isolate shared a similar number of A with
SAMA and K1 parasites.
T1526C mutation in field isolates
The proportion of isolates harbouring wild, mutant and
mixed alleles did not significantly differ between groups
from Senegal and Benin (p = 0.4). The proportion of SM
and UM cases did not differ either in these groups
(p = 0.2). However age ranges were significantly different
between the groups (p< 0.0001) as more adults were
included in Senegal.Analysis including mixed isolates
The amplification of the resa2 region encompassing the
T1526C mutation was obtained in 39 SM isolates and 21
UM isolates from Senegal (Additional file 1 and Add-
itional file 2). RFLP analysis using MseI enzyme was per-
formed as the restriction site is affected by the T1526C
mutation. The T1526C mutation was found in six of the
SM isolates (15.4%). In UM isolates, only one sample
harboured the mutant allele (4.8%) in association with
the wild allele. The mutant allele was not found more
frequently in SM cases than in UM cases (p = 0.2). The
presence of the mutant allele was not associated either
with parasitaemia (p = 0.3).
In the group of Beninese children, resa2 PCR amplifi-
cation was successful for all isolates. Sixteen isolates
(15.8%) harboured the T1526C allele, 11 among the se-
vere cases and five among the UM cases. Six isolates
(three corresponding to SM and three to UM) harboured
both wild and mutant alleles. The mutant allele was not
found more frequently in SM cases than in UM cases
(p = 0.2) (Table 1). There was a trend towards the associ-
ation of the presence of the mutant allele and parasit-
aemia> 4% (p = 0.06).
When data from Senegal and Benin were pooled, se-
verity of cases was not significantly associated but
showed a trend towards association with the resa2
T1526C mutation (p = 0.09).
Analysis excluding mixed isolates
In the group of Senegalese patients, there was a trend to-
wards the association of the presence of the mutant allele
and severity of malaria (p = 0.06). The presence of the
mutant allele was not associated with parasitaemia
(p = 0.3).
In the group of Beninese children, there was a trend
towards the association of the presence of the mutant al-
lele and severity of malaria (p = 0.08) (Table 2). There
was a trend towards the association of the presence of
the mutant allele and parasitaemia > 4% (p = 0.05). In
multivariate analysis, this association became statistically
significant (p = 0.03) (Table 3).
When data from Senegal and Benin were pooled, severity
of cases was significantly associated with the resa2 T1526C
mutation, Odds Ratio= 5.7; Confidence Interval 95% :
[1.26-26.1](p = 0.008). The association between the pres-
ence of mutant allele and severity of malaria remained sig-
nificant when age and origin of isolates (Benin or Senegal)
were controlled for in a bivariate analysis.
Association of T1526C mutation and in vitro growth rate
Multiplication rates of P. falciparum parasites isolated
from SM or UM patients in Benin patients were com-
pared in a short-term, 72-hour in vitro culture growth
assay (Table 4). After 72 hours in vitro culture, parasite
Table 2 Factors associated with the presence of the resa2
T1526C allele in P. falciparum infected Beninese patients.
Analysis without mixed isolates
T1526C SNP Wild allele p value
Infected patients n (%) 10 (10,5) 85 (89,5)
Variables
Sex
Male 8 (80) 53 (62) 0.3
Female 2 (20) 32 (38)
Age (months)
Median (min-max) 35 (24–108) 48 (4–114) 0.5
In quartile
<=24 months 4 (40) 24 (28)
24.1-48 2 (20) 22 (26) 0.6
48.1-84 3 (30) 17 (20)
>84 1 (10) 22 (26)
Malaria
Severe 8 (80) 43 (51) 0.08
Uncomplicated 2 (20) 42 (49)
Parasitaemia (%)
Median (min-max) 7 (0.2-36) 3 (0.01-65) 0.2
By category
>4% 7 (70) 32 (38) 0.05
<=4% 3 (30) 53 (62)
Malaria prophylaxis
Yes 3 (38) 30 (41) 0.8
No 5 (62) 44 (59)
Splenomegalia
Yes 2 (20) 27 (32) 0.4
No 8 (80) 58 (78)
Table 3 Multivariate analysis of factors associated with
the resa2 T1526C allele in P. falciparum infected Beninese
patients (n = 95)
Variables Odds ratio 95% confidence interval p value
Parasitaemia
<=4% 1
>4% 5.7 1.2-26.9 0.03
Sex
Female 1
Male 8.3 0.8-83.7 0.07
Table 1 Factors associated with the presence of the resa2
T1526C allele in P. falciparum infected Beninese patients.
Analysis with mixed isolates
T1526C SNP Wild allele p value
Infected patients n (%) 16 (16) 85 (84)
Variables
Sex
Male 8 (50) 53 (62) 0.3
Female 8 (50) 32 (38)
Age (months)
Median (min-max) 39 (7–120) 48 (4–114)
In quartile
<=24 months 6 (38) 24 (28)
24.1-48 4 (25) 22 (26) 0.9
48.1-84 3 (19) 17 (20)
>84 3 (19) 22 (26)
Malaria
Severe 11 (69) 43 (51) 0.2
Uncomplicated 5 (31) 42 (49)
Parasitaemia (%)
Median (min-max) 7 (0.2-36) 3 (0.01-65) 0.2
By category
>4% 10 (63) 32 (38) 0.06
<=4% 6 (37) 53 (62)
Malaria prophylaxis
Yes 5 (42) 30 (41) 0.9
No 7 (58) 44 (59)
Splenomegalia
Yes 5 (31) 27 (32) 0.9
No 11 (69) 58 (78)
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lates (37%) and 7 UM isolates (16%). Isolates showing
higher multiplication rates were more frequently asso-
ciated with SM (odds ratio 5.9, IC95% 1.6-21.6) (Table 4).
Five out of the eight SM isolates (62.5%) carrying the
resa2 T1526C allele have multiplication rates ranging
from 1.5 to 4.3. Two out of three SM parasites with the
T1526 mutation that failed to grow were collected from
patients who had taken anti-malarial prophylaxis.
Growth culture failed for all mixed isolates. All UM
parasites with parasite multiplication rate over 1.5 have
the wild resa2 allele.
Discussion
As P. falciparum is haploid in humans, isolates containing
both resa2 T1526C mutant and wild alleles corresponded
to multiclonal isolates. Multilocus genotyping of the Sene-
galese isolates showed quite a large genetic diversity, andimportantly outlined that most patients (SM and UM)
were infected by at least two distinct clones [21]. In the
present study some isolates (one UM case Senegal, three
SM cases and three UM cases in Benin) harboured both
wild and mutant resa2 alleles. As the proportion of each
Table 4 Association of the parasite multiplication rate
(interquartiles) with severe malaria in 97 Beninese
patients
Severe
Malaria
(n = 53)
Uncomplicated
Malaria (n = 44)
Odds ratio
severe malaria
95%
confidence
interval
p
Parasite multiplication rate (PMR)
≤0.1 13 (25) 8 (18) 3.5 0.9-13.02
0.11-
0.7
15 (28) 16 (36) 2.03 0.6-6.7 0.03
0.71-
1.7
6 (12) 13 (30) 1
>1.7 19 (35) 7 (16) 5.9 1.6-21.6
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appeared difficult to correlate the severity of the clinical
access with the presence of resa2 mutant for those isolates.
Indeed, the analysis including those mixed isolates did not
show an association of the presence of the mutant allele
and severity of malaria. Conversely, such an association
was found in the analysis excluding the mixed isolates. In
addition, an association of the presence of the mutant al-
lele and parasitaemia > 4% was found in the group of Be-
ninese children.
To gain statistical power, data from Beninese and
Senegalese groups were combined to assess the associ-
ation between mutant allele and severity of malaria. This
association, observed for the combined series (n = 154),
was not significant for each group alone probably due to
a lack of power, but a trend towards this association was
found for each group.
About 14% of isolates obtained from Senegal and
Benin harboured mutant T1526C parasites. Sequencing
of resa2 cDNAs showed that the mutation T1526C
affects an internal stop codon and restores a unique
open reading frame. Thus, all mutant parasites theoretic-
ally have the ability to encode a full-length protein.
RESA2 protein as RESA1 has a PEXEL motif and is
member of the pHISTb (Plasmodium helical interspersed
subtelomeric family) protein family [26] suggesting that
as its sister protein RESA1, it could be secreted out of
the parasite and contribute in vivo to remodelling the
host cell and possibly the erythrocyte membrane so as to
favour high-density infections.
In multivariate analysis, parasitaemia >4%, appeared as a
factor associated with the presence of mutant T1526C para-
sites in the group of Beninese children. It should be stressed
that parasitaemia >4% is by itself a criterion, including the
case in the severe category of malaria attack. Thus, it is not
surprising that the presence of mutant T1526C parasites
was associated with both parasitaemia >4% and SM. In-
deed, it has been reported that P. falciparum isolates from
patients with severe malaria had higher multiplication rates
in vitro than those from uncomplicated malaria [27]. Asimilar observation was obtained in the series from Benin
using short-term, 72-hour in vitro culture growth assay.
Moreover, five out of six parasites harbouring the T1526C
mutation, and collected from patients who had not taken
anti-malarial prophylaxis, were able to multiply in culture, a
prevalence far above the one observed for parasites carrying
the wild allele. A rapid multiplication rate leading to high
parasite density before an effective protective response is
attained may contribute to severity [27-29].
Most severe cases of the series (43 of 51 in Benin, 33
of 39 in Senegal) were not due to parasites harbouring
the T1526C mutation. There is no simple one-to-one
correlation between the clinical syndrome and the patho-
genic processes involved in SM, probably reflecting the
contribution of multiple host and parasite factors to mal-
aria pathogenesis. Yet the T1526C mutation is one of the
first parasite SNPs associated with SM. Further work is
needed to understand how the RESA2 protein contri-
butes to pathogenesis and whether or not it fulfils a role
similar to RESA1 in providing the parasites with a better
fitness and survival under febrile conditions.
Conclusions
There is an urgent need to better understand the patho-
genesis of malaria, especially its severe forms. Identifica-
tion of parasite factors that contribute to increased
fitness or are targeted by host defense responses may
lead to new diagnostic, prognostic and therapeutic tools.
Parasite virulence factors are probably intrinsic compo-
nents of the process that leads to SM. However, the con-
founding effect of the rapidly acquired immunity to
these life-threatening parasites and the potential bias due
to host genetic background could hamper their detec-
tion. Other studies in various geographic settings and
probably including more patients are now required to
replicate these results and to answer the questions raised
by these results.
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presenting with severe P. falciparum malaria.
Additional file 2: Characteristics of 30 Senegalese patients
presenting with uncomplicated P. falciparum malaria.
Additional file 3: Characteristics of 54 Beninese patients presenting
with severe P. falciparum malaria.
Additional file 4: Characteristics of 47 Beninese patients presenting
with uncomplicated P. falciparum malaria.
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